EUVIMEDEUVIMED entdecken
Übersichtsarbeit

CCL2‐CCR2 signaling axis in obesity and metabolic diseases

Yue Wu iD, Yanchun Ma

Journal of Cellular Physiology · 2024-04 · 239 (4)

DOI: 10.1002/jcp.31192 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Cellular Physiology, online erschienen am 29.01.2024. Verfasst von Yue Wu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Shandong Provincial Key Laboratory of Animal Resistance Biology, Center for Cell Structure and Function, Collaborative Innovation Center of Cell Biol…. Hauptthemen laut MEDLINE: Metabolic Diseases, Obesity, Receptors, CCR2. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 144 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity and metabolic diseases, such as insulin resistance, type 2 diabetes, nonalcoholic fatty liver disease, and cardiovascular ailments, represent formidable global health challenges, bearing considerable implications for both morbidity and mortality rates. It has become increasingly evident that chronic, low‐grade inflammation plays a pivotal role in the genesis and advancement of these conditions. The involvement of C‐C chemokine ligand 2 (CCL2) and its corresponding receptor, C‐C chemokine receptor 2 (CCR2), has been extensively documented in numerous inflammatory maladies. Recent evidence indicates that the CCL2/CCR2 pathway extends beyond immune cell recruitment and inflammation, exerting a notable influence on the genesis and progression of metabolic syndrome. The present review seeks to furnish a comprehensive exposition of the CCL2‐CCR2 signaling axis within the context of obesity and metabolic disorders, elucidating its molecular mechanisms, functional roles, and therapeutic implications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metabolic DiseasesObesityReceptors, CCR2HumansChemokine CCL2InflammationLigandsSignal TransductionAnimalsMice

Stichwörter der Autor:innen

CCL2CCR2adipose tissueinflammationmetabolic syndrome

Substanzen

Chemokine CCL2LigandsReceptors, CCR2CCL2 protein, humanCCR2 protein, human

Autor:innen und Institutionen

  • Shandong Provincial Key Laboratory of Animal Resistance Biology, Center for Cell Structure and Function, Collaborative Innovation Center of Cell Biology in Universities of Shandong, College of Life Sciences, Shandong No…

ORCID-Profile: Yue Wu

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Shandong Province

Zitieren

APA

Wu, Y., & Ma, Y. (2024). CCL2‐CCR2 signaling axis in obesity and metabolic diseases. Journal of Cellular Physiology, 239(4). https://doi.org/10.1002/jcp.31192

Vancouver

Wu Y, Ma Y. CCL2‐CCR2 signaling axis in obesity and metabolic diseases. Journal of Cellular Physiology. 2024;239(4). doi:10.1002/jcp.31192

BibTeX
@article{Wu2024,
  author = {Wu, Yue and Ma, Yanchun},
  title = {CCL2‐CCR2 signaling axis in obesity and metabolic diseases},
  journal = {Journal of Cellular Physiology},
  year = {2024},
  volume = {239},
  number = {4},
  doi = {10.1002/jcp.31192}
}
Kostenlos starten →